Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 204

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 204
---
million and non-cash equity issuance costs of approximately $ 6.2million. As of December 31, 2024, there are 1,032,080Class E Common Stock Warrants outstanding to purchase 64,506shares of common stock that were not included in the Class E Warrant Inducement. As part of the 2025 Reverse Stock Split on January 28, 2025, the number of shares of common stock the Class G Common Stock Warrants are exercisable into was reset from 381,004to 1,621,463and the exercise price of the Class G Common Stock Warrants was reset from $ 16.00to $ 3.7596. F-16 REVELATION BIOSCIENCES, INC.
Notes to the Consolidated Financial Statements 7. Preferred Stock Revelation Authorized Preferred Stock The Company is authorized under its articles of incorporation, as amended, up to 5,000,000shares of preferred stock, which may be issued as designated by the Board of Directors without stockholder approval. As of December 31, 2024 and as of the date of this Report, there were noshares of preferred stock issued and outstanding. Series A Preferred Stock On December 19, 2022, the Company closed the sale of one share of the Company’s Series A Preferred Stock, par value $ 0.001per share, to its Chief Executive Officer for $ 5,000.00. The outstanding share of Series A Preferred Stock was automatically redeemed for $ 5,000.00on January 30, 2023 upon the effectiveness of the Certificate of Amendment implementing the reverse stock split and the increase in authorized shares of common stock of the Company. 8. Common Stock The Company is authorized under its articles of incorporation, as amended, to issue up to 500,000,000shares of common stock, par value $ 0.001per share. Common Stock Issuance during the year ended December 31, 2023 On February 13, 2023, the Company issued 6,017shares of its common stock in connection with the February 2023 Public Offering. The Company received net cash proceeds of $ 14.0million. From February 14, 2023 to April 6, 2023, the Company issued 699shares of common stock in connection with notices of cash exercise for Class C Pre-Funded Warrants issued in connection with the February 2023 Public Offering with a total